Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life
Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.
Pharma’s Ghost Labs Find New Life
Pharma’s Ghost Labs Find New Life

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

Finding new tenants for former drug development sites isn’t always easy. But a new, thriving industry has materialized to do just that.

pharmaceutical industry
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma
Catherine Offord | Oct 14, 2019
The move will allow the Belgium-headquartered biopharmaceutical giant to boost its work on treatments for rare diseases.
Immune Cell Bank Bets on Future CAR T Success
Immune Cell Bank Bets on Future CAR T Success
Nicoletta Lanese | Aug 16, 2019
The company Cell Vault offers to hold consumers’ T cells for later use, but scientists suggest the service would benefit very few users.
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Some Data Backing Novartis Gene-Therapy Approval Manipulated: FDA
Nicoletta Lanese | Aug 7, 2019
The agency is now evaluating the implications of the corrupted data behind Zolgensma and whether to “take action” against the pharmaceutical company.
Chemist Behind the Combined Oral Contraceptive Dies at 102
Chemist Behind the Combined Oral Contraceptive Dies at 102
Catherine Offord | Jul 2, 2019
George Rosenkranz was part of a team in Mexico City that first synthesized norethindrone in 1951.

Miracle Elixirs
Miracle Elixirs
Bob Grant | Apr 1, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
Opinion: The “Money Culture” in Academic Biomedical Research
Opinion: The “Money Culture” in Academic Biomedical Research
David Rubenson | Mar 29, 2019
A drive for revenue is damaging basic science.
Esketamine, a Treatment for Depression, Receives FDA Approval
Esketamine, a Treatment for Depression, Receives FDA Approval
Carolyn Wilke | Mar 6, 2019
The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Bristol-Myers Squibb to Buy Celgene for $74 Billion
Catherine Offord | Jan 3, 2019
The deal between the two biopharmaceutical giants will boost the purchaser’s cancer drug portfolio.
Data Sharing in Action: When Drug Companies Open Their Trial Vaults
Data Sharing in Action: When Drug Companies Open Their Trial Vaults
Abby Olena | Dec 3, 2018
YODA, a program facilitated by Yale University researchers, has successfully distributed clinical trial records from Johnson & Johnson and Medtronic to external researchers since 2013.